Skip to main content
Main menu
Pipeline
Clinical
Discovery
Compounds
Regimens
Drug Targets
Developers
Trial Sites
Trials
News
Meetings
Members
Our Members
Core Group
About
Join Us
Pipelines
Anti-TB
Biologics
Host Directed
Clinical Biologics Pipeline
Trials for Market Approval
Download PPT
Advancing
Either
No
Yes
Marketed
On
NCE
On
Repurposed
On
Trials for Market Approval
On
Pre-Clinical (GLP)
Celecoxib WBA
SPRINT-TB (National University of Singapore)
Hsp65 DNA
TGF-B inhib +Cox 2 inhibitor
Phase 2
CC-11050, Auranofin, Everolimus, Vitamin D3 plus Rifabutin-modified TB Therapy
The Aurum Institute NPC, Medicines Development for Global Health
Phase 2 Safety, Efficacy & Biomarker Response of HDTs Added to Standard Therapy
Phase 3
Immunoxel